Insider · CIK 0001665000

Gibbs Michael Terrence

Reports to the SEC for 1 company · LEXINGTON, MA

sec.gov

Transactions

Companies

Filings

CIK

0001665000

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2024-11-04	T2 Biosystems, Inc.Restricted Stock UnitsA Award	General Counsel	AAward	+190K sh	—	—	190,000
2024-11-04	T2 Biosystems, Inc.Restricted Stock UnitsA Award	General Counsel	AAward	+190K sh	—	—	190,000
2024-02-24	T2 Biosystems, Inc.M Exercise/Conversion	General Counsel	MExercise/Conversion	+29 sh	—	—	135
2024-02-24	T2 Biosystems, Inc.Restricted Stock UnitsM Exercise/Conversion	General Counsel	MExercise/Conversion	−29 sh	—	—	0
2024-02-20	T2 Biosystems, Inc.M Exercise/Conversion	General Counsel	MExercise/Conversion	+40 sh	—	—	106
2024-02-20	T2 Biosystems, Inc.Restricted Stock UnitsM Exercise/Conversion	General Counsel	MExercise/Conversion	−40 sh	—	—	40
2023-03-28	T2 Biosystems, Inc.S Sale	General Counsel	SSale	−239 sh	$0.48	−$114.959	6,612
2023-03-24	T2 Biosystems, Inc.M Exercise/Conversion	General Counsel	MExercise/Conversion	+333 sh	—	—	6,850
2023-03-24	T2 Biosystems, Inc.Restricted Stock UnitsM Exercise/Conversion	General Counsel	MExercise/Conversion	−333 sh	—	—	0
2023-03-24	T2 Biosystems, Inc.M Exercise/Conversion	General Counsel	MExercise/Conversion	+334 sh	—	—	6,851
2023-03-24	T2 Biosystems, Inc.Restricted Stock UnitsM Exercise/Conversion	General Counsel	MExercise/Conversion	−334 sh	—	—	0
2023-02-28	T2 Biosystems, Inc.S Sale	General Counsel	SSale	−1,585 sh	$0.59	−$935.15	6,517
2023-02-24	T2 Biosystems, Inc.M Exercise/Conversion	General Counsel	MExercise/Conversion	+2,914 sh	—	—	8,102
2023-02-24	T2 Biosystems, Inc.Restricted Stock UnitsM Exercise/Conversion	General Counsel	MExercise/Conversion	−2,914 sh	—	—	2,914
2023-02-22	T2 Biosystems, Inc.S Sale	General Counsel	SSale	−2,145 sh	$0.65	−$1,394.25	5,188
2023-02-20	T2 Biosystems, Inc.M Exercise/Conversion	General Counsel	MExercise/Conversion	+4,000 sh	—	—	7,333
2023-02-20	T2 Biosystems, Inc.Restricted Stock UnitsM Exercise/Conversion	General Counsel	MExercise/Conversion	−4,000 sh	—	—	8,000
2022-04-07	T2 Biosystems, Inc.P Purchase	General Counsel	PPurchase	+10K sh	$0.49	+$4,900	166,651
2022-03-24	T2 Biosystems, Inc.M Exercise/Conversion	General Counsel	MExercise/Conversion	+16.7K sh	—	—	165,441
2022-03-24	T2 Biosystems, Inc.F Tax Payment	General Counsel	FTax Payment	−8,790 sh	$0.44	−$3,875.511	156,651
2022-03-24	T2 Biosystems, Inc.Restricted Stock UnitsM Exercise/Conversion	General Counsel	MExercise/Conversion	−16.7K sh	—	—	16,667
2022-02-24	T2 Biosystems, Inc.M Exercise/Conversion	General Counsel	MExercise/Conversion	+146K sh	—	—	215,642
2022-02-24	T2 Biosystems, Inc.F Tax Payment	General Counsel	FTax Payment	−76.9K sh	$0.45	−$34.5K	138,775
2022-02-24	T2 Biosystems, Inc.Restricted Stock UnitsM Exercise/Conversion	General Counsel	MExercise/Conversion	−146K sh	—	—	291,439
2022-02-24	T2 Biosystems, Inc.M Exercise/Conversion	General Counsel	MExercise/Conversion	+146K sh	—	—	225,642
2022-02-24	T2 Biosystems, Inc.F Tax Payment	General Counsel	FTax Payment	−76.9K sh	$0.45	−$34.5K	148,775
2022-02-24	T2 Biosystems, Inc.Restricted Stock UnitsM Exercise/Conversion	General Counsel	MExercise/Conversion	−146K sh	—	—	291,439
2022-02-21	T2 Biosystems, Inc.M Exercise/Conversion	General Counsel	MExercise/Conversion	+10K sh	—	—	85,198
2022-02-21	T2 Biosystems, Inc.F Tax Payment	General Counsel	FTax Payment	−5,275 sh	$0.47	−$2,458.15	79,923
2022-02-21	T2 Biosystems, Inc.Restricted Stock UnitsM Exercise/Conversion	General Counsel	MExercise/Conversion	−10K sh	—	—	0
2022-02-21	T2 Biosystems, Inc.M Exercise/Conversion	General Counsel	MExercise/Conversion	+10K sh	—	—	75,198
2022-02-21	T2 Biosystems, Inc.F Tax Payment	General Counsel	FTax Payment	−5,275 sh	$0.47	−$2,458.15	69,923
2022-02-21	T2 Biosystems, Inc.Restricted Stock UnitsM Exercise/Conversion	General Counsel	MExercise/Conversion	−10K sh	—	—	0
2022-02-20	T2 Biosystems, Inc.Restricted Stock UnitsA Award	General Counsel	AAward	+600K sh	—	—	600,000
2022-02-20	T2 Biosystems, Inc.Restricted Stock UnitsA Award	General Counsel	AAward	+600K sh	—	—	600,000
2021-03-25	T2 Biosystems, Inc.S Sale	General Counsel	SSale	−8,758 sh	$1.56	−$13.7K	73,256
2021-03-24	T2 Biosystems, Inc.M Exercise/Conversion	General Counsel	MExercise/Conversion	+16.7K sh	—	—	82,014
2021-03-24	T2 Biosystems, Inc.Restricted Stock UnitsM Exercise/Conversion	General Counsel	MExercise/Conversion	−16.7K sh	—	—	33,333
2021-02-24	T2 Biosystems, Inc.Restricted Stock UnitsA Award	General Counsel	AAward	+437K sh	—	—	437,158
2021-02-23	T2 Biosystems, Inc.S Sale	General Counsel	SSale	−7,280 sh	$2.06	−$15K	65,347
2021-02-21	T2 Biosystems, Inc.M Exercise/Conversion	General Counsel	MExercise/Conversion	+10K sh	—	—	72,627
2021-02-21	T2 Biosystems, Inc.Restricted Stock UnitsM Exercise/Conversion	General Counsel	MExercise/Conversion	−10K sh	—	—	10,000
2020-03-24	T2 Biosystems, Inc.Stock Option (Right to Buy)A Award	General Counsel	AAward	+100K sh	—	—	100,000
2020-03-24	T2 Biosystems, Inc.Restricted Stock UnitsA Award	General Counsel	AAward	+50K sh	—	—	50,000
2020-02-24	T2 Biosystems, Inc.S Sale	General Counsel	SSale	−5,808 sh	$0.82	−$4,762.56	60,779
2020-02-21	T2 Biosystems, Inc.M Exercise/Conversion	General Counsel	MExercise/Conversion	+10K sh	—	—	66,587
2020-02-21	T2 Biosystems, Inc.Restricted Stock UnitsM Exercise/Conversion	General Counsel	MExercise/Conversion	+10K sh	—	—	20,000
2020-02-11	T2 Biosystems, Inc.S Sale	General Counsel	SSale	−3,200 sh	$0.77	−$2,464	56,587
2020-02-09	T2 Biosystems, Inc.M Exercise/Conversion	General Counsel	MExercise/Conversion	+5,833 sh	—	—	59,787
2020-02-09	T2 Biosystems, Inc.Restricted Stock UnitsM Exercise/Conversion	General Counsel	MExercise/Conversion	+5,833 sh	—	—	0

Recent filings

Accepted (ET)
Jan 24
Gibbs Michael Terrence0000950170-25-000592
SEC(opens sec.gov)
Feb 274
Gibbs Michael Terrence0000950170-24-021242
SEC(opens sec.gov)
Feb 204
Gibbs Michael Terrence0000950170-24-017073
SEC(opens sec.gov)
Apr 64
Gibbs Michael Terrence0000950170-23-012031
SEC(opens sec.gov)
Apr 54/A
Gibbs Michael Terrence0000899243-23-010680
SEC(opens sec.gov)
Mar 284
Gibbs Michael Terrence0000950170-23-010276
SEC(opens sec.gov)
Mar 94
Gibbs Michael Terrence0000899243-23-007725
SEC(opens sec.gov)
Apr 114
Gibbs Michael Terrence0000899243-22-014416
SEC(opens sec.gov)
Mar 284/A
Gibbs Michael Terrence0000899243-22-012511
SEC(opens sec.gov)
Mar 284/A
Gibbs Michael Terrence0000899243-22-012514
SEC(opens sec.gov)

Companies

T2 Biosystems, Inc.General Counsel

Address

101 HARTWELL AVENUE

LEXINGTON, MA, 02421